Meyka Pro banner
Epiminder Limited

Epiminder Limited (EPI.AX) Stock Overview

Explore Epiminder Limited’s financial performance, market position, analyst ratings, and future outlook.

EPI.AX●ASX
HealthcareMedical - Devices
$0.27
$0.005(1.92%)
Australian Market opens in 53h 3m

Epiminder Limited (EPI.AX)

Meyka AI Score

Z

Key Financials

Market Cap52M
P/E RatioN/A
EPS (TTM)$-0.28
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$0.02
3 Months$0.00
1 Year Target$0.00

EPI.AX Stock Analysis & Investment Overview (ASX)

Our AI-powered analysis of Epiminder Limited (ASX: EPI.AX) gives investors deep insight into how the stock performs on the ASX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Epiminder Limited's ASX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EPI.AX on the ASX shows an RSI of 33.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the ASX listing.

Key metrics behind Epiminder Limited's ASX-traded stock include a P/E ratio of N/A and a market capitalization of 52M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EPI.AX on the ASX.

Price Performance (ASX: EPI.AX)

1-Day Change
-7.69%
5-Day Change
-9.43%
1-Month Change
-9.43%
3-Month Change
-23.81%
6-Month Change
-50.00%
Year-to-Date (YTD) Change
-76.47%
1-Year Change
-81.68%
3-Year Change
-81.68%
5-Year Change
-81.68%
All-Time (Max) Change
-81.68%

Contact Information

NaN
West Podium, Mezzanine 2, Melbourne, VIC, 3000

Company Facts

IPO DateNov 30, 2025
CountryAU
Actively Trading

Frequently Asked Questions